John B. Hess, chief executive officer of Hess Corporation, has filed 58 Form 4 transactions across two companies, with a total sell value of $495.2 million and zero open-market purchases. The overwhelming majority of activity centers on Chevron (CVX), where his recent filings show a consistent sell bias. On August 3, 2026, Hess executed eight open-market sales totaling roughly $157.3 million, with individual transactions ranging from $4.9 million to $52.9 million. Those sales were paired with five option exercises valued at approximately $50.3 million, a mechanical step that typically precedes or accompanies share disposal. He also reported four "J" transactions on the same date, which are adjustments with no cash value.
The pattern extends back to May 20, 2026, when Hess filed five CVX sales worth about $27.7 million, including a single $11.4 million disposition. His only other recent activity is a series of zero-value "A" grants in Goldman Sachs (GS) and CVX, which are compensation awards rather than discretionary trades. Across all 58 filings, there are no purchases, no acquisitions, and no gifts. The recent window shows 13 sales and no buys, reinforcing a one-directional flow of shares out of his holdings.
Hess's selling is concentrated in CVX, the company he joined as a director following Chevron's acquisition of Hess Corp. The dollar figures are large, but the structure is routine for an executive holding post-merger equity: periodic option exercises followed by same-day sales. His GS grants are compensation, not conviction trades. The data offers no signal of accumulation, only a steady reduction of CVX exposure through open-market sales.
AI-assisted summary